Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Lucid Diagnostics Inc
(NQ:
LUCD
)
0.8004
+0.0026 (+0.33%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Lucid Diagnostics Inc
< Previous
1
2
Next >
PAVmed and Lucid Diagnostics Welcome New Full-Time Investor Relations Team
January 12, 2022
From
PAVmed Inc. and Lucid Diagnostics Inc.
Via
Business Wire
Lucid Diagnostics to Participate in a Fireside Chat at the 24th Annual Needham Virtual Growth Conference
January 06, 2022
From
Lucid Diagnostics Inc.
Via
Business Wire
PAVmed Subsidiary Lucid Diagnostics Launches EsoGuard Telemedicine Program in Partnership with UpScriptHealth
December 01, 2021
From
Lucid Diagnostics Inc.
Via
Business Wire
Lucid Diagnostics to Present at Canaccord Genuity Virtual MedTech, Diagnostics and Digital Health & Services Forum
November 17, 2021
From
Lucid Diagnostics Inc. PAVmed Inc.
Via
Business Wire
PAVmed and Lucid Provide Business Update and Preliminary Third Quarter 2021 Financial Results
November 16, 2021
From
PAVmed Inc. and Lucid Diagnostics Inc.
Via
Business Wire
PAVmed Subsidiary Lucid Diagnostics Launches Next Phase of Lucid Test Centers
November 11, 2021
From
Lucid Diagnostics Inc.
Via
Business Wire
PAVmed and Lucid to Hold Joint Business Update Conference Call on November 16, 2021
November 03, 2021
From
PAVmed Inc. and Lucid Diagnostics Inc.
Via
Business Wire
Lucid Diagnostics’ EsoGuard Esophageal DNA Test Wins “Diagnostics Innovation of the Year” Award
October 28, 2021
From
Lucid Diagnostics Inc.
Via
Business Wire
ADDING MULTIMEDIA Lucid Diagnostics Appoints Suman Verma MD, PhD as Chief Scientific Officer
October 21, 2021
From
Lucid Diagnostics Inc.
Via
Business Wire
Lucid Diagnostics Appoints Suman Verma MD, PhD as Chief Scientific Officer
October 21, 2021
From
Lucid Diagnostics Inc.
Via
Business Wire
Lucid Diagnostics Announces Closing of Nasdaq Initial Public Offering
October 18, 2021
From
Lucid Diagnostics Inc.
Via
Business Wire
Lucid Diagnostics Announces Pricing of Initial Public Offering
October 13, 2021
From
PAVmed Inc.
Via
Business Wire
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.